Kim O'Malia Health Care Management

Kim O'Malia holds an MBA in Health Care Management from Regis University and a Bachelor of Science in Health Care Administration from Bellevue University. With a robust career in clinical management, Kim O'Malia currently serves as Director at Puma Biotechnology, Inc. since 2019. Previous roles include Associate Director and Clinical Trial Manager at PUMA BIOTECHNOLOGY, and Sr. Project Leader at Integrium. Kim O'Malia has extensive experience as Clinical Study Manager at Medicis Pharmaceuticals, Project Leader/Study Manager at Duke Clinical Research Institute, and various positions at Boston Scientific and Eli Lilly and Company, contributing significantly to clinical operations and data management.